Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LRRK2-IN-3 is a potent, selective, orally active LRRK2 inhibitor that crosses the blood-brain barrier with an IC50 value of 0.6 nM in hPBMCs. LRRK2-IN-3 can be used to study Parkinson's disease.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 491,500 |
50 mg | 約10-14 週間 | ¥ 639,500 |
100 mg | 約10-14 週間 | ¥ 808,000 |
説明 | LRRK2-IN-3 is a potent, selective, orally active LRRK2 inhibitor that crosses the blood-brain barrier with an IC50 value of 0.6 nM in hPBMCs. LRRK2-IN-3 can be used to study Parkinson's disease. |
分子量 | 518.99 |
分子式 | C25H29ClF2N6O2 |
CAS No. | 2641054-60-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LRRK2-IN-3 2641054-60-4 Inhibitor inhibitor inhibit